Sign in
4

Changes in Ownership

Cocrystal Pharma, Inc. Filed Acc 0001415889-15-003894

Options or other derivatives

  • INTERIM CFO acquired 100,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Dale Curtis INTERIM CFO 2015-11-24 Grant or award · Stock options (Right to Buy) +100,000 100,000 D
Loading xslF345X03/form4-11252015_011147.xml…